Stay updated on Daratumumab Adds to VRd in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Adds to VRd in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Adds to VRd in Multiple Myeloma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A banner was added above the ClinicalTrials.gov navigation announcing NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and linking to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T17:09:56.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.2 instead of v3.7.1 on the forbidden-access page.
    Difference
    0.2%
    Check dated 2026-10-17T16:59:04.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 Forbidden page; no study details are shown.
    Difference
    0.2%
    Check dated 2026-10-10T17:47:40.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the multiple myeloma study is no longer displayed; the page shows a 403 Forbidden message instead of the study details, results, and locations.
    Difference
    18%
    Check dated 2026-10-03T17:06:25.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study content with an access-denied screen and removing the study record details from view.
    Difference
    18%
    Check dated 2026-09-19T18:29:08.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Core study metadata changed: the condition 'Multiple Myeloma' and its related topics link were removed. NIH funding notes for 2018 and 2023 were added, and the revision tag updated to v3.6.6.
    Difference
    0.2%
    Check dated 2026-08-29T20:54:14.000Z thumbnail image

Stay in the know with updates to Daratumumab Adds to VRd in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Adds to VRd in Multiple Myeloma Clinical Trial page.